BrightPath BiotherapeuticsLtd. (4594.TSE) Q1 2026 Earnings

13FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-4.42
-3.62
-2.83
-2.03

Details

Expected EPS
N/A
Actual EPS
-4.42318681242
Surprise EPS
-4.42
Surprise Percent
+∞%

Description

BrightPath BiotherapeuticsLtd. (4594.TSE) has reported earnings of -4.42318681242 per share for Q1 2026.

0 Comments

Share your thoughts